[go: up one dir, main page]

MX374220B - Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. - Google Patents

Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.

Info

Publication number
MX374220B
MX374220B MX2015011825A MX2015011825A MX374220B MX 374220 B MX374220 B MX 374220B MX 2015011825 A MX2015011825 A MX 2015011825A MX 2015011825 A MX2015011825 A MX 2015011825A MX 374220 B MX374220 B MX 374220B
Authority
MX
Mexico
Prior art keywords
treatment
nepentesin
related conditions
gluten intolerance
recombinant nepenthesin
Prior art date
Application number
MX2015011825A
Other languages
English (en)
Other versions
MX2015011825A (es
Inventor
David Schriemer
Hynek Mrazek
Martial Rey
Petr Man
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of MX2015011825A publication Critical patent/MX2015011825A/es
Publication of MX374220B publication Critical patent/MX374220B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/23—Aspartic endopeptidases (3.4.23)
    • C12Y304/23012—Nepenthesin (3.4.23.12)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Una composición para usarse en el tratamiento o inhibición de intolerancia al gluten, en donde la composición comprende nepentesina recombinante seleccionada de nepentesina I recombinante, nepentesina II recombinante, o una sal o una combinación de las mismas.
MX2015011825A 2012-11-21 2014-03-14 Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. MX374220B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261729210P 2012-11-21 2012-11-21
US201261797040P 2012-11-27 2012-11-27
US13/843,369 US9005610B2 (en) 2012-11-21 2013-03-15 Treatment of gluten intolerance and related conditions
PCT/CA2014/000258 WO2014138927A1 (en) 2012-11-21 2014-03-14 Treatment of gluten intolerance and related conditions

Publications (2)

Publication Number Publication Date
MX2015011825A MX2015011825A (es) 2016-05-31
MX374220B true MX374220B (es) 2025-03-05

Family

ID=50728145

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015006419A MX2015006419A (es) 2012-11-21 2013-11-20 Tratamiento de la intolerancia al gluten y padecimientos relacionados.
MX2015011825A MX374220B (es) 2012-11-21 2014-03-14 Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015006419A MX2015006419A (es) 2012-11-21 2013-11-20 Tratamiento de la intolerancia al gluten y padecimientos relacionados.

Country Status (15)

Country Link
US (7) US9005610B2 (es)
EP (1) EP2922568A1 (es)
JP (1) JP6412876B2 (es)
KR (1) KR102296428B1 (es)
CN (1) CN105007934B (es)
AU (1) AU2013350261B2 (es)
CA (1) CA2892474C (es)
DK (1) DK3004340T3 (es)
ES (1) ES2821771T3 (es)
HR (1) HRP20201459T1 (es)
HU (1) HUE050868T2 (es)
IL (2) IL238912B (es)
MX (2) MX2015006419A (es)
PT (1) PT3004340T (es)
WO (2) WO2014078935A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions
CN105492602B (zh) * 2013-03-15 2021-01-05 科德克希思公司 对麸质不耐受以及相关病症的治疗
WO2015192211A1 (en) 2014-06-16 2015-12-23 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
WO2017106798A2 (en) * 2015-12-16 2017-06-22 Nepetx, Llc Compositions and methods for treating gluten intolerance and disorders arising therefrom
AU2018335849B2 (en) * 2017-09-20 2023-04-13 Aarhus Universitet Nepenthesin-1 derived resistance to fungal pathogens in major crop plants
JP7390398B2 (ja) * 2019-04-02 2023-12-01 サミ－サビンサ グループ リミテッド グルテン不耐性の治療管理のための方法および組成物
TWI864494B (zh) * 2022-11-17 2024-12-01 國立中興大學 天冬胺酸蛋白酶於水解麩質蛋白之用途、編碼該天冬胺酸蛋白酶之核酸分子、生產該天冬胺酸蛋白酶之方法及其應用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DK81193D0 (da) * 1993-07-06 1993-07-06 Novo Nordisk As Enzym
JP3767831B2 (ja) * 1995-06-14 2006-04-19 木村 健 ヘリコバクター・ピロリ除菌用組成物
JP3521635B2 (ja) 1996-08-07 2004-04-19 日本電信電話株式会社 映像生成方法および映像生成システム
JPH1149697A (ja) * 1997-08-01 1999-02-23 Nisshin Flour Milling Co Ltd ストレス抑制剤及びストレス抑制用食品
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
CA2475972C (en) 2002-02-14 2017-07-11 Felix Hausch Enzyme treatment of foodstuffs for celiac sprue
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
JP4415244B2 (ja) * 2003-02-21 2010-02-17 グリコ栄養食品株式会社 小麦蛋白質にプロテアーゼを限定的に作用させて得られる食品素材
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
US20060095096A1 (en) 2004-09-09 2006-05-04 Debenedictis Leonard C Interchangeable tips for medical laser treatments and methods for using same
US8119385B2 (en) 2005-03-04 2012-02-21 Bp Corporation North America Inc. Nucleic acids and proteins and methods for making and using them
WO2007054988A1 (en) * 2005-10-11 2007-05-18 Mofin S.R.L. 'gluten-free' blu-veined dairy products intended for persons affected by celiac disease
US8119125B2 (en) 2005-10-11 2012-02-21 Alvine Pharmaceuticals, Inc. Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
WO2008034648A1 (en) 2006-04-05 2008-03-27 Metanomics Gmbh Process for the production of a fine chemical
US8148105B2 (en) 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
US20100322912A1 (en) * 2007-12-10 2010-12-23 Chaitan Khosla Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients
WO2010021752A1 (en) 2008-08-21 2010-02-25 Alvine Pharmaceuticals, Inc. Formulation for oral administration of proteins
JP2011049697A (ja) 2009-08-25 2011-03-10 Panasonic Corp フリッカ検出装置、撮像装置、フリッカ検出プログラム、及び、フリッカ検出方法
US20110200574A1 (en) 2010-02-02 2011-08-18 Jolly James F Use of proteases for gluten intolerance
JP2013523133A (ja) 2010-03-30 2013-06-17 アルヴィン ファーマシューティカルズ インコーポレーティッド グルテンを分解するためのプロテアーゼ
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
US9005610B2 (en) 2012-11-21 2015-04-14 Nepetx, Llc Treatment of gluten intolerance and related conditions

Also Published As

Publication number Publication date
US10266818B2 (en) 2019-04-23
HRP20201459T1 (hr) 2020-12-11
ES2821771T3 (es) 2021-04-27
MX2015006419A (es) 2015-12-15
WO2014078935A1 (en) 2014-05-30
US11725198B2 (en) 2023-08-15
JP6412876B2 (ja) 2018-10-24
DK3004340T3 (da) 2020-09-21
US9745565B2 (en) 2017-08-29
EP2922568A1 (en) 2015-09-30
CA2892474C (en) 2022-06-21
KR102296428B1 (ko) 2021-09-01
US20170067040A1 (en) 2017-03-09
PT3004340T (pt) 2020-09-30
CA2892474A1 (en) 2014-05-30
US9005610B2 (en) 2015-04-14
WO2014138927A1 (en) 2014-09-18
US10982201B2 (en) 2021-04-20
IL283484A (en) 2021-06-30
US20140140980A1 (en) 2014-05-22
AU2013350261A1 (en) 2015-07-09
IL238912B (en) 2021-06-30
IL238912A0 (en) 2015-07-30
AU2013350261B2 (en) 2018-12-06
US9623092B2 (en) 2017-04-18
JP2016501853A (ja) 2016-01-21
US20150265686A1 (en) 2015-09-24
CN105007934A (zh) 2015-10-28
US20200040322A1 (en) 2020-02-06
MX2015011825A (es) 2016-05-31
US20140186330A1 (en) 2014-07-03
KR20150123783A (ko) 2015-11-04
US20150290301A1 (en) 2015-10-15
US20210230569A1 (en) 2021-07-29
HUE050868T2 (hu) 2021-01-28
CN105007934B (zh) 2019-02-05

Similar Documents

Publication Publication Date Title
CL2016002971A1 (es) Combinación.
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CL2015002891A1 (es) Deaza-purinonas macrocíclicas para el tratamiento de infecciones virales.
CL2014002873A1 (es) Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer.
CL2016001231A1 (es) Compuestos de inhibidor de autotaxina
MX374220B (es) Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados.
CL2015002698A1 (es) Nuevos compuestos y composiciones para la inhibicion de fasn
BR112015002524A2 (pt) derivados de alquilpirimidina para o tratamento de infecções virais e outras doenças.
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
MX2021000007A (es) Formulaciones de enzalutamida.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
BR112015001838A2 (pt) composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
UY34037A (es) Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
CL2012003385A1 (es) Tratamiento para la incontinencia.
EA201400838A1 (ru) ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ
UY34545A (es) Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios.
CO7020867A2 (es) Formulaciones de anticuerpo y metodos
CL2015003019A1 (es) Derivados biaromáticos antibacterianos
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
BR112014025041B8 (pt) Composição farmacêutica
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
CL2014001861A1 (es) Compuestos derivados de bencil sulfonamida, inhibidores de mogat-2; compuesto cristalino; composicion farmaceutica; y su uso en el tratamiento de la hipertrigliceridemia.
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.

Legal Events

Date Code Title Description
FG Grant or registration